SYRA earnings

Revenue increase led by Population Health's 261% YoY Expansion Gross Margin Improves Substantially to 31.7%, up 14.6 Percentage Points YoY Continued Efficiency Gains Cut Q1 2025 Net Losses by Over Two Thirds Compared to Q1 2024 A conference call will be held today, Thursday, May 8, at 9:00 am ET CARMEL, Ind., May 8, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for the first quarter ended March 31, 2025.

Conference call will be held on Thursday, May 8, at 9:00 a.m. ET CARMEL, Ind., May 1, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA), ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that it will report financial results for the three months ended March 31, 2025, on Thursday, May 8, 2025, before market open. The Company will host a conference call that same day, May 8, 2025, at 9:00 a.m. ET, to discuss the results. Interested parties can access the con

2024 Population Health Revenue Acceleration to 132% YoY Q4 2024 Net Losses Cut Nearly in Half Compared to Q4 2023, Highlighting Major Efficiency Gains Continued Momentum with New Customer Wins and Contract Extensions Driving Sustainable Growth A conference call will be held today, Tuesday, March 11 at 9:00 am ET CARMEL, Ind., March 11, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for fourth quarter and full year ended December 31, 2024.

Conference call will be held on Tuesday, March 11 at 9:00 a.m. ET CARMEL, Ind., March 4, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that it will report financial results for its fourth quarter and full year 2024 ended December 31, 2024, on Tuesday, March 11, 2025, before the market opens. The company will host a conference call that same day, March 11, 2025, at 9:00 a.m. ET, to discuss the results.

Achieved Net Revenue of $2.3 million, ~42% Growth Over the Prior Year Quarter Gross Margins Increased Following Shift in Operational Strategy Net Loss Narrowed to $417,535 ($0.06 per share), a Significant Improvement from the $1.39 million ($0.21 per share) Net Loss in Q2 of 2024 Aiming to Attain Profitability in 2025 through Targeted Revenue Growth and Cost-Efficiency Measures Conference call will be held today, Tuesday, October 29th at 9:00 AM ET CARMEL, Ind., Oct. 29, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company") a healthcare technology company driving better health through impactful, innovative solutions, announced today its financial results for

In the news release, Syra Health To Discuss Third Quarter 2024 Financial Results, issued 22-Oct-2024 by Syra Health over PR Newswire, we are advised by the company that the webcast link listed in the second and fourth paragraphs was incorrect. The URL should read "https://syrahealth.com/ir/presentations/q3-2024-earnings-call" rather than "https://dev.syrahealth.com/ir/presentations/q3-2024-earnings-call" as originally issued inadvertently. The complete, corrected release follows: Syra Health To Discuss Third Quarter 2024 Financial Results Conference call will be held on Tuesday, October 29 at 9:00 AM ET CARMEL, Ind., Oct. 22, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra He

Conference call will be held on Tuesday, October 29 at 9:00 AM ET CARMEL, Ind., Oct. 22, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it will report financial results for the three months ended September 30, 2024, on Tuesday, October 29, 2024, before the market opens. The Company has scheduled a conference call that same day, October 29, at 9:00 a.m. ET, to review the results. Interested parties can access the conference call

Conference call will be held today, Thursday, August 8 at 9:00 am ET CARMEL, Ind., Aug. 8, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company") a healthcare technology company powering better health by providing meaningful solutions, announced today its financial results for the second quarter ended June 30, 2024. Q2 2024 Financial Highlights Revenue of $2.0 million in 2Q24 compared to $1.0 million in 2Q23.Gross margins in 2Q24 increased 468 basis points compared to 2Q23.High-margin business units, including Population Health, grew 347% and co

Conference call will be held on Thursday, August 8 at 9:00 AM ET CARMEL, Ind., Aug. 1, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it will report financial results for the three months ended June 30, 2024, on Thursday, August 8, 2024, before the market opens. The Company has scheduled a conference call that same day, August 8, 2024, at 9:00 a.m. ET, to review the results. Interested parties can access the conference call via

Conference call will be held today, Thursday, May 9 at 9:00 am ET CARMEL, Ind., May 9, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company") a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today its financial results for the first quarter ended March 31, 2024. Q1 2024 Financial Highlights Revenue of $1.7 million in 1Q24 compared to $1.2 million in 1Q23.Business units excluding Healthcare Workforce grew 333% and comprised 19% of total revenues in 1Q24, vers

Conference call will be held on Thursday, May 9 at 9:00 AM ET CARMEL, Ind., May 1, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company") a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today that it will report financial results for its first quarter 2024 ended March 31, 2024, on Thursday, May 9, 2024, before the market opens. The Company has scheduled a conference call that same day, May 9, 2024, at 9:00 a.m. ET, to review the results. Interested parties

Conference call will be held today, Monday, March 25 at 9:00am ET CARMEL, Ind., March 25, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company"), a healthcare consulting company with a mission to improve healthcare by providing innovative services and technology solutions, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023. 2023 Financial Highlights 2023 revenue of $5.5 million compared to $5.6 million in 2022.Business units excluding Healthcare Workforce grew 250% and comprised 23% of total reve

Conference call will be held on Monday, March 25 at 9:00 a.m. ET CARMEL, Ind., March 19, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company") a healthcare consulting company with a mission to improve healthcare by providing innovative services and technology solutions, announced today that it will report financial results for its fourth quarter and fiscal year 2023 ended December 31, 2023, on Monday, March 25, 2024, before the market opens. The Company has scheduled a conference call for that same day, March 25, 2024, at 9:00 a.m. ET, to review the results.